JLJimin Lee

Jimin Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jimin Lee has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Remimazolam in pediatric surgery under general anesthesia: a case series

    by Hong-Sik Shon, Seyeon Park, Jung-Pil Yoon, Yeong Min Yoo, Jimin Lee, Da Eun Lee, Hee Young Kim

    Remimazolam is a promising drug for general anesthesia due to its rapid onset, short duration, and short context-sensitive half-life. However, its use in pediatric patients remains off-label, and limited prospective data have been published. Herein, we report successful anesthesia using remimazolam in pediatric patients who had a history of epilepsy or required shared airway surgery. In all cases, remimazolam provided general anesthesia, and flumazenil was used for reversal with rapid recovery. Remimazolam offers advantages for pediatric anesthesia in scenarios with a risk of seizure or shared airway surgery. However, the potential for higher bispectral index values and the risk of anaphylaxis in dextran-allergic patients necessitate caution and further research.


  • Open Access

    Total intravenous anesthesia using remimazolam for patients with heart failure with reduced ejection fraction: a case series

    by Jimin Lee, Ji-Uk Yoon, Gyeong-Jo Byeon, Hong-Sik Shon, Ahhyeon Yi, Hee Young Kim

    Patients with heart failure undergoing surgery that requires general anesthesia face substantial perioperative risks; however, clear guidelines are not available for anesthesia management in patients with a reduced left ventricular ejection fraction. Traditional intravenous and volatile anesthetics require careful administration to prevent severe hypotension and bradycardia in patients with heart failure. Remimazolam has emerged as a promising alternative to conventional anesthetics because of its reduced cardiovascular depressive effects. We present three cases illustrating the successful use of remimazolam to induce and maintain general anesthesia in patients with heart failure and reduced cardiac function. Our cases demonstrate the safe use of remimazolam for general anesthesia in patients with heart failure and a reduced ejection fraction.

  • Open Access

    Use of oxygen reserve index during bronchoscopic balloon dilation for subglottic stenosis in a patient with left ventricular assist device implantation -a case report-

    by Jimin Lee, Minwoo Chung, Eui-Suk Sung, Jung-Pil Yoon, Yeong Min Yoo, Jaesang Bae, Hee Young Kim

    Background: Monitoring the oxygenation status is crucial during general anesthesia to ensure patient safety. Although noninvasive pulse oximetry is commonly used to monitor percutaneous oxygen saturation (SpO2), it may not accurately reflect changes in oxygen partial pressure when the latter is excessively high or low. The oxygen reserve index (ORi) provides real-time information about the oxygen reserve status.Case: We present a case of successful management of subglottic stenosis using balloon bronchoscopy in an infant with a left ventricular assist device implantation under ORi monitoring to predict hypoxemia during the surgical procedure.Conclusions: Utilizing ORi monitoring during anesthesia for procedures involving apnea in critically ill infants can help predict impending desaturation before a drop in SpO2 occurs, allowing anesthesiologists to effectively anticipate and manage the apnea period. Continuous ORi monitoring offers valuable insights during surgical procedures, especially in infants with compromised respiratory and cardiovascular functions.


  • Open Access

    Concordance of esophageal and tracheal temperatures in patients using breathing circuit with heated wire humidifier: A prospective observational study

    by Ji-Uk Yoon, Gyeong-Jo Byeon, Hee Young Kim, Hye-Jin Kim, Yeong Min Yoo, Jaesang Bae, Jimin Lee

    No study has compared tracheal and esophageal temperatures when a breathing circuit with a heated wire humidifier was used. This study aimed to investigate the correlation between tracheal and esophageal temperatures in patients using a breathing circuit with heated wire humidifiers. Tracheal temperatures measured by the cuff sensor correlated well with esophageal temperatures while using a heated wire humidifier breathing circuit in patients with anesthesia duration of > 2 hours. Thirty-eight patients who underwent general anesthesia for > 2 hours were enrolled. Tracheal and esophageal temperatures were recorded at 5-minute intervals, starting from the insertion of the esophageal temperature probe to the end of anesthesia. The temperatures were compared by Bland-Altman analysis, calculating the proportion of tracheal temperature measurements within ± 0.25°C of esophageal temperatures, and linear mixed-effects model. Univariate analysis was performed to assess whether any variables influenced the proportion of differences within ± 0.25°C. Results: After excluding 4 patients with an anesthesia duration of < 2 hours, data from 34 patients (1163 sets of tracheal and esophageal temperatures) were analyzed. Concordance correlation coefficient was 0.78. The overall mean bias (95% limits of agreement) between the tracheal and esophageal temperatures was −0.16°C (−0.65°C to 0.34°C). The percentage of temperature differences within ± 0.25°C was 73.5% ± 32.3, with a median of 89.4% [0,100]. The linear mixed-effects model revealed that the estimated intercept was 0.17°C with a 95% confidence interval (CI) of 0.13°C to 0.22°C. The duration of anesthesia and the number of temperature measurements were associated with higher concordance between the tracheal and esophageal temperatures in univariate analysis.

  • Open Access

    Multimodal management strategies for chronic pain after spinal surgery: a comprehensive review

    by Jung-Pil Yoon, Hong-Sik Son, Jimin Lee, Gyeong-Jo Byeon

    “Chronic pain after spinal surgery” (CPSS) is a nonspecific term for cases in which the end result of surgery generally does not meet the preoperative expectations of the patient and surgeon. This term has replaced the previous term i.e., failed back surgery syndrome. CPSS is challenging for both patients and doctors. Despite advancements in surgical techniques and technologies, a subset of patients continue to experience persistent or recurrent pain postoperatively. This review provides an overview of the multimodal management for CPSS, ranging from conservative management to revision surgery. Drawing on recent research and clinical experience, we aimed to offer insights into the diverse strategies available to improve the quality of life of CPSS patients.


  • Open Access

    Vasopressor requirements and hemodynamic stability during anesthesia using remimazolam and sevoflurane in patients undergoing minimally invasive aortic valve replacement surgery: a prospective randomized controlled study

    by Jimin Lee, Sang-Wook Shin, Ji-Uk Yoon, Hye-Jin Kim, Jung-Pil Yoon, Hong-Sik Shon, Da Eun Lee, Hee Young Kim

    Anesthetic agents can cause hypotension, and patients with severe aortic stenosis (AS) require special attention. This study compared the effects of remimazolam versus sevoflurane anesthesia on hemodynamics in patients with severe AS undergoing minimally invasive aortic valve replacement (AVR). Patients were assigned to the remimazolam (R) or sevoflurane (S) group. Group R received remimazolam 6 mg/kg/h for induction and 1–2 mg/kg/h for maintenance with remifentanil. Group S received 1% propofol at 1–2 mg/kg for induction and sevoflurane with remifentanil for maintenance. Vasopressor requirement and hypotensive events were compared. Sixty-four patients were enrolled, and one patient was excluded from the study. The infusion rate of norepinephrine was lower in group R during post-cardiopulmonary bypass (CPB) (0.040±0.051 vs. 0.085±0.080 mcg/kg/min, P=0.03). The proportion of hypotension was lower in group R during post-CPB (80.2%±21.5% vs. 91.9%±25.2%, P=0.04), and the entire duration of anesthesia (66.5%±16.9% vs. 76.0%±16.2%, P=0.03). Compared to conventional sevoflurane anesthesia, remimazolam-based total intravenous anesthesia was associated with more stable hemodynamics and reduced vasopressor requirement during pre-CPB, and post-CPB in patients with severe AS undergoing minimally invasive AVR. The clinical research was registered at ClinicalTrials.gov (Ref: NCT05864625).